Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Breast Cancer

  Free Subscription


3 Ann Oncol
7 Ann Surg Oncol
7 Anticancer Res
1 BMC Cancer
1 Br J Cancer
4 Breast Cancer
1 Breast Cancer Res
9 Breast Cancer Res Treat
83 Breast J
1 Cancer
1 Cancer Lett
2 Cancer Res
5 Clin Breast Cancer
2 Eur J Cancer
1 Eur J Surg Oncol
2 Eur Radiol
1 Exp Cell Res
1 Gene
1 Int J Cancer
2 J Biol Chem
1 J Clin Oncol
3 Lancet
3 NPJ Breast Cancer
1 Oncogene
1 PLoS One
1 Radiol Artif Intell
1 Radiol Cardiothorac Imaging
2 Radiology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Oncol

  1. MILES D, Gligorov J, Andre F, Cameron D, et al
    Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer.
    Ann Oncol. 2021 Jul 1. pii: S0923-7534(21)02026.
    PubMed         Abstract available

  2. MILES D, Ciruelos E, Schneeweiss A, Puglisi F, et al
    Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
    Ann Oncol. 2021 Jul 2. pii: S0923-7534(21)02105.
    PubMed         Abstract available

  3. BURSTEIN HJ, Curigliano G, Thurlimann B, Weber WP, et al
    CUSTOMIZING LOCAL AND SYSTEMIC THERAPIES FOR WOMEN WITH EARLY BREAST CANCER: The St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.
    Ann Oncol. 2021 Jul 6. pii: S0923-7534(21)02104.
    PubMed         Abstract available

    Ann Surg Oncol

  4. CRIPPA S, Giannone F, Schiavo Lena M, Belfiori G, et al
    R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma.
    Ann Surg Oncol. 2021;28:4602-4612.
    PubMed         Abstract available

  5. HE Q, Chen J, Zhou K, Jin C, et al
    Effect of Additional Trastuzumab in Neoadjuvant and Adjuvant Treatment for Patients with Resectable HER2-Positive Gastric Cancer.
    Ann Surg Oncol. 2021;28:4413-4422.
    PubMed         Abstract available

  6. PAWLOSKI KR, Wen HY, Tadros AB, Abbate K, et al
    Concordance Between 21-Gene Recurrence Scores in Multifocal or Multicentric Breast Carcinomas Differs by Age and Histologic Subtype.
    Ann Surg Oncol. 2021;28:4256-4262.
    PubMed         Abstract available

  7. PILTIN MA, Hoskin TL, Day CN, Shumway DA, et al
    Use of the Twelve-Gene Recurrence Score for Ductal Carcinoma in Situ and Its Influence on Receipt of Adjuvant Radiation and Hormonal Therapy.
    Ann Surg Oncol. 2021;28:4294-4303.
    PubMed         Abstract available

  8. SORAN A, Sezgin E, Ozbas S, Dogan L, et al
    Reply: The Effect of Primary Surgery in Patients with Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-center, Registry Study.
    Ann Surg Oncol. 2021 Jul 7. pii: 10.1245/s10434-021-10396.

  9. BLOOM JA, Sekigami Y, Young R, Macera L, et al
    ASO Visual Abstract: Discordance in Oncotype DX Breast Recurrence Score(R) Results for Bilateral Breast Cancer.
    Ann Surg Oncol. 2021 Jul 8. pii: 10.1245/s10434-021-10429.

  10. BLOOM JA, Sekigami Y, Young R, Macera L, et al
    Discordance in Oncotype DX Breast Recurrence Score((R)) Results for Bilateral Breast Cancer.
    Ann Surg Oncol. 2021 Jul 9. pii: 10.1245/s10434-021-10387.
    PubMed         Abstract available

    Anticancer Res

  11. VIEIRA JF, Peixoto AP, Murta EFC, Michelin MA, et al
    Prophylactic Dendritic Cell Vaccination in Experimental Breast Cancer Controls Immunity and Hepatic Metastases.
    Anticancer Res. 2021;41:3419-3427.
    PubMed         Abstract available

  12. KIM CY, Kim YC, Oh JH, Kim MH, et al
    HOXB5 Confers Tamoxifen Resistance in Breast Cancer Cells and Promotes Tumor Aggression and Progression.
    Anticancer Res. 2021;41:3409-3417.
    PubMed         Abstract available

  13. RAJBONGSHI L, Noh MH, Kim YS, Hur DY, et al
    Effects of Epstein-Barr Virus Infection on the Response of Human Breast Cancer Cells to Nicotine.
    Anticancer Res. 2021;41:3449-3458.
    PubMed         Abstract available

  14. SUZUKI C, Yamada A, Adachi S, Shima H, et al
    Bromodomain-containing Protein 4 Is a Favourable Prognostic Factor in Breast Cancer Patients.
    Anticancer Res. 2021;41:3597-3606.
    PubMed         Abstract available

  15. TANG A, Mooney CM, Beattie G, Cohan CM, et al
    Health Equity Within Inequity: Timing of Diagnostic Breast Cancer Care in an Underserved Medical Population.
    Anticancer Res. 2021;41:3607-3613.
    PubMed         Abstract available

  16. YAMANOUCHI K, Maeda S, Takei D, Koga Y, et al
    Pretreatment Absolute Lymphocyte Count and Neutrophil-to-lymphocyte Ratio Are Prognostic Factors for Stage III Breast Cancer.
    Anticancer Res. 2021;41:3625-3634.
    PubMed         Abstract available

  17. MARCHICA P, D'Arpa S, Magno S, Rossi C, et al
    Integrated Treatment of Breast Cancer-related Lymphedema: A Descriptive Review of the State of the Art.
    Anticancer Res. 2021;41:3233-3246.
    PubMed         Abstract available

    BMC Cancer

  18. NAKAYAMA T, Yoshinami T, Yasojima H, Kittaka N, et al
    Real-world effectiveness of post-trastuzumab emtansine treatment in patients with HER2-positive, unresectable and/or metastatic breast cancer: a retrospective observational study (KBCSG-TR 1917).
    BMC Cancer. 2021;21:795.
    PubMed         Abstract available

    Br J Cancer

  19. WANG Y, Ye F, Liang Y, Yang Q, et al
    Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies.
    Br J Cancer. 2021 Jul 5. pii: 10.1038/s41416-021-01424.
    PubMed         Abstract available

    Breast Cancer

  20. GIORELLO MB, Matas A, Marenco P, Davies KM, et al
    CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients.
    Breast Cancer. 2021 Jul 9. pii: 10.1007/s12282-021-01270.
    PubMed         Abstract available

  21. PHAM TM, Nguyen DK, Pham HM, Le DC, et al
    Average lifespan shortened due to breast cancer in Australia, 1990-2015.
    Breast Cancer. 2021 Jul 8. pii: 10.1007/s12282-021-01271.
    PubMed         Abstract available

  22. SANGHA MS, Baker R, Ahmed M
    Axillary dissection versus axillary observation for low risk, clinically node-negative invasive breast cancer: a systematic review and meta-analysis.
    Breast Cancer. 2021 Jul 9. pii: 10.1007/s12282-021-01273.
    PubMed         Abstract available

  23. TOYODA Y, Katanoda K, Ishii K, Yamamoto H, et al
    Negative impact of the COVID-19 state of emergency on breast cancer screening participation in Japan.
    Breast Cancer. 2021 Jul 9. pii: 10.1007/s12282-021-01272.
    PubMed         Abstract available

    Breast Cancer Res

  24. YAGHJYAN L, Austin-Datta RJ, Oh H, Heng YJ, et al
    Associations of reproductive breast cancer risk factors with breast tissue composition.
    Breast Cancer Res. 2021;23:70.
    PubMed         Abstract available

    Breast Cancer Res Treat

  25. MUNOZ-MONTANO WR, Cabrera-Galeana P, De la Garza-Ramos C, Azim HA Jr, et al
    Prognosis of breast cancer diagnosed during pregnancy and early postpartum according to immunohistochemical subtype: A matched case-control study.
    Breast Cancer Res Treat. 2021;188:489-500.
    PubMed         Abstract available

  26. POLLEY MC, Dickler MN, Sinnwell J, Tenner K, et al
    A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy.
    Breast Cancer Res Treat. 2021 Jul 3. pii: 10.1007/s10549-021-06319.
    PubMed         Abstract available

  27. BENGTSSON Y, Sandsveden M, Borgquist S, Manjer J, et al
    Serum zinc and dietary intake of zinc in relation to risk of different breast cancer subgroups and serum levels as a marker of intake: a prospective nested case-control study.
    Breast Cancer Res Treat. 2021 Jul 5. pii: 10.1007/s10549-021-06318.
    PubMed         Abstract available

  28. KIM JY, Jeon E, Kwon S, Jung H, et al
    Prediction of pathologic complete response to neoadjuvant chemotherapy using machine learning models in patients with breast cancer.
    Breast Cancer Res Treat. 2021 Jul 5. pii: 10.1007/s10549-021-06310.
    PubMed         Abstract available

  29. YAN CH, Coleman C, Nabulsi NA, Chiu BC, et al
    Associations between frailty and cancer-specific mortality among older women with breast cancer.
    Breast Cancer Res Treat. 2021 Jul 9. pii: 10.1007/s10549-021-06323.
    PubMed         Abstract available

  30. PARK J, Tacam MJ, Chauhan G, Cohen EN, et al
    Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression.
    Breast Cancer Res Treat. 2021 Jul 9. pii: 10.1007/s10549-021-06316.
    PubMed         Abstract available

  31. LIU X, Qiu R, Xu M, Meng M, et al
    KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer.
    Breast Cancer Res Treat. 2021 Jul 8. pii: 10.1007/s10549-021-06325.
    PubMed         Abstract available

  32. WALLNER LP, Abrahamse P, Gargaro JG, Radhakrishnan A, et al
    Improving the delivery of team-based survivorship care after primary breast cancer treatment through a multi-level intervention: a pilot randomized controlled trial.
    Breast Cancer Res Treat. 2021 Jul 7. pii: 10.1007/s10549-021-06257.
    PubMed         Abstract available

  33. BURKS HE, Matossian MD, Rhodes LV, Phamduy T, et al
    ZEB2 regulates endocrine therapy sensitivity and metastasis in luminal a breast cancer cells through a non-canonical mechanism.
    Breast Cancer Res Treat. 2021 Jul 6. pii: 10.1007/s10549-021-06256.
    PubMed         Abstract available

    Breast J

  34. SALEMIS NS, Mourtzoukou D
    Encapsulated papillary carcinoma of the breast.
    Breast J. 2021;27:280-283.

  35. NIAKAN S, Patino A, Jadhav N, Hadro J, et al
    Syringomatous adenoma of the nipple with microcalcifications on mammography: A case report.
    Breast J. 2021;27:170-172.
    PubMed         Abstract available

  36. NIA ES, Adrada BE, Whitman GJ, Candelaria RP, et al
    MRI features of pseudoangiomatous stromal hyperplasia with histopathological correlation.
    Breast J. 2021;27:242-247.
    PubMed         Abstract available

  37. JACKSON CR, Felty CC, Marotti JD, Rosenkranz KM, et al
    Encapsulated papillary carcinoma with and without frank invasion: Comparison of clinicopathologic features and role of axillary staging.
    Breast J. 2021;27:209-215.
    PubMed         Abstract available

  38. DARRACH H, Kraenzlin FS, Khavanin N, He W, et al
    Pectoral placement of tissue expanders affects inpatient opioid use.
    Breast J. 2021;27:126-133.
    PubMed         Abstract available

  39. MASOOD S
    Changing the philosophy, direction, and the governance of The Breast Journal as it moves towards becoming an "Open Access" journal in 2022.
    Breast J. 2021;27:5-6.

  40. BALANOFF CR, Larson KE, Robinson LA, Wagner JL, et al
    Secondary angiosarcoma following catheter-based brachytherapy.
    Breast J. 2021;27:173-175.
    PubMed         Abstract available

  41. MICHEL-RUDDY JA, Tran TT, Ozao-Choy JJ, Venegas RJ, et al
    Intraductal papilloma: An unusual presentation.
    Breast J. 2021;27:278-279.

  42. FEKI J, Boudawara O, Makni S, Sellami-Boudawara T, et al
    An uncommon breast metastasis of mediastinal neuroblastoma within a child: A case report.
    Breast J. 2021;27:377-379.
    PubMed         Abstract available

  43. ARAB W, Moubarak M, Fattah S, Khazen J, et al
    Periductal stromal tumor of the breast in a young lady: A case report.
    Breast J. 2021;27:380-383.
    PubMed         Abstract available

  44. MINGRINO J, Wang Y
    Apocrine ductal carcinoma in situ associated with testosterone therapy in a transgender individual.
    Breast J. 2021;27:475-477.
    PubMed         Abstract available

  45. RODRIGUEZ-ORTEGA A, Ferro T, Borras JM
    What outcomes do breast care nurses achieve when their competencies are aligned with international guidelines? A systematic scoping review from 2014 to 2019.
    Breast J. 2021;27:397-399.

  46. TRIHIA HJ, Lampropoulos P, Karelis L, Souka E, et al
    Tall cell carcinoma with reversed polarity: A case report of a very rare breast tumor entity and mini-review.
    Breast J. 2021;27:369-376.
    PubMed         Abstract available

  47. SHEU TG, Hunt KK, Middleton LP
    MYC and NOTCH1-positive postradiation cutaneous angiosarcoma of the breast.
    Breast J. 2021;27:264-267.
    PubMed         Abstract available

  48. CHOTAI N, Lim SK
    Imaging features of steatocystoma multiplex- back to basics.
    Breast J. 2021;27:389-390.

  49. ORAL H, Turkyilmaz Z, Arslan Kahraman DI, Kaya C, et al
    B-cell lymphoblastic lymphoma of unilateral primary breast mass in a boy aged 11 years.
    Breast J. 2021;27:271-272.

  50. KARZAI S, Lehman JC
    HSV-1 mastitis in a 30-year-old woman.
    Breast J. 2021;27:268-270.
    PubMed         Abstract available

  51. DURAN-MARTINEZ M, Torres-Lorite M, Calleja-Lozano R, Leon-Salinas C, et al
    Primary breast pyoderma gangrenosum: an uncommon cause of breast ulcer.
    Breast J. 2021;27:276-277.

  52. NITTA T, Kimura K, Tominaga T, Ikari A, et al
    Malignant solitary fibrous tumor of the breast.
    Breast J. 2021;27:391-393.

  53. KARWOWSKI P, Lumley D, Stokes D, Pavlica M, et al
    Atypical ductal hyperplasia on core needle biopsy: Surgical outcomes of 200 consecutive cases from a high-volume breast program.
    Breast J. 2021;27:287-290.
    PubMed         Abstract available

  54. JU T, Tsai J
    Surgical excision of BioZorb device eroding through the nipple-areolar complex one year postoperatively: A case report.
    Breast J. 2021;27:256-257.
    PubMed         Abstract available

  55. MUKHTAR RA, Brabham CE, Guo R, Abel MK, et al
    Accuracy of sentinel lymph node biopsy in invasive lobular carcinoma of the breast: Factors associated with false negatives.
    Breast J. 2021;27:406-408.

  56. PATEL A, Hoda SA, Swistel AJ
    Mammary myofibroblastoma in a male: A classic case.
    Breast J. 2021;27:181-182.

  57. COCHRANE K, Bell JL, Heidel RE, Orucevic A, et al
    Adenosquamous carcinoma of the breast, an uncommon diagnosis with poor prognosis-Lessons learned from a 12-year analysis of the National Cancer Database.
    Breast J. 2021;27:165-169.
    PubMed         Abstract available

  58. MICHALOPOULOS NV, Mitrousias A, Karathanasis PV, Kalles V, et al
    A novel way of hook wire placement for surgical resection of suspicious breast lesions using the stereotactic vacuum assisted breast biopsy table.
    Breast J. 2021;27:403-405.
    PubMed         Abstract available

  59. CASTELO M, Brown Z, Schellenberg AE, Mills JK, et al
    Abnormal screens among nonmutation carriers in the High Risk Ontario Breast Screening Program.
    Breast J. 2021;27:423-431.
    PubMed         Abstract available

  60. WANG H, Xue Y, Xu H
    (18) F-FDG PET/CT findings in a giant malignant phyllodes breast tumor.
    Breast J. 2021;27:183-184.

  61. AHMED YS, Abd El Maksoud WM, Sultan MH, El-Bakoury EA, et al
    Latissimus Dorsi flap enhancement by lipofilling as an immediate breast reconstruction technique for skin-preserving mastectomy.
    Breast J. 2021;27:222-230.
    PubMed         Abstract available

  62. BEKENY JC, Singh T, Luvisa K, Wirth PJ, et al
    Delivery of nipple-sparing mastectomy within a single healthcare system: The impact of provider preferences.
    Breast J. 2021;27:149-157.
    PubMed         Abstract available

  63. POPLACK SP, Patel AK, Salter A, Langley Blanton H, et al
    The impact of adjunctive tomosynthesis on screening mammography outcomes in two widely diverse radiology practices.
    Breast J. 2021;27:13-20.
    PubMed         Abstract available

  64. LAW W, Cao X, Wright FC, Slodkowska E, et al
    Adequacy of invasive and in situ breast carcinoma margins in radioactive seed and wire-guided localization lumpectomies.
    Breast J. 2021;27:134-140.
    PubMed         Abstract available

  65. ALAKUS H, Goksu M, Pehlivanoglu B
    Breast metastasis of lower extremity liposarcoma.
    Breast J. 2021;27:65-66.

  66. HUO D, Sheng ZX, Han GY, Wang WH, et al
    An angiosarcoma in the breast associated with Kasabach-Merritt syndrome: Breast Images.
    Breast J. 2021;27:62-64.

  67. REIS J, Boavida J, Bahrami N, Lyngra M, et al
    Breast sarcoidosis: Clinical features, imaging, and histological findings.
    Breast J. 2021;27:44-47.
    PubMed         Abstract available

  68. PARK HM, Lim HS, Ki SY, Lee HJ, et al
    Chest-wall abscess presenting as a breast lump.
    Breast J. 2021;27:67-68.

  69. YAHYAOUI Y, Ouertani E, Zenzri Y, Charfi L, et al
    Diagnosis and treatment of synchronous breast and small bowel non-Hodgkin's lymphoma.
    Breast J. 2021;27:60-61.

  70. SCHUNCK TS, Veiga DF, Cavagna FA, Jr LE G, et al
    Brazilian version of the Breast-Q((c)) -Breast-Conserving Therapy Module 2.0: Translation, cross-cultural adaptation, and reproducibility.
    Breast J. 2021;27:72-74.

  71. AMORIM RBF, Campos FSM, Silveira LL, Archangelo Junior I, et al
    Effectiveness of Brazilian national health policy for mammogram screening in women aged over 50 years.
    Breast J. 2021;27:82-83.

    Biomarkers for CDK4/6 inhibitor efficacy.
    Breast J. 2021;27:103.

  73. WEINFURTNER RJ, Carter T
    Transition to digital breast tomosynthesis-guided biopsies: Results and complications compared to stereotactic biopsies.
    Breast J. 2021;27:21-26.
    PubMed         Abstract available

  74. O'BEIRN E, Elliott JA, Neary C, O'Connell A, et al
    Congenital arteriovenous malformation of the breast associated with giant hairy nevus.
    Breast J. 2021;27:58-59.

  75. BATT J, Ainsworth R, Rayter Z, Nickells J, et al
    Sensitivity and missed cancer rate in the symptomatic breast clinic-A retrospective cohort study of 40 323 patients.
    Breast J. 2021;27:248-251.
    PubMed         Abstract available

  76. CADENA-SEMANATE RE, Estrella-Tapia LF, Contreras-Yametti FI, Contreras-Yametti JE, et al
    Adalimumab in a patient with refractory idiopathic granulomatous mastitis: A case report.
    Breast J. 2021;27:99-102.

  77. ACEA-NEBRIL B, Garcia-Novoa A, Cereijo-Garea C
    Cosmetic sequelae after oncoplastic breast surgery: long-term results of a prospective study.
    Breast J. 2021;27:35-43.
    PubMed         Abstract available

  78. NORMAN C, Lafaurie G, Uhercik M, Kasem A, et al
    Novel wire-free techniques for localization of impalpable breast lesions-A review of current options.
    Breast J. 2021;27:141-148.
    PubMed         Abstract available

  79. CELOTTO F, Tropea S, Rastrelli M, Saibene T, et al
    Solitary biceps muscle metastasis from neuroendocrine breast tumor.
    Breast J. 2021;27:185-187.

  80. SANDERS LM, Morgan D
    An alternative to MRI-guided core biopsy for challenging lesions: Preliminary experience with marker clip placement under MRI followed by mammographic or ultrasound-guided biopsy.
    Breast J. 2021;27:198-200.

  81. LIM GH, Lee J, Eng TC, Ng RP, et al
    Evaluation of Virtual Breast Oncoplastic Surgery Simulator (VBOSS) as a training tool.
    Breast J. 2021;27:194-197.

  82. ATALLAH D, Arab W, El Kassis N, Nasser Ayoub E, et al
    Breast and tumor volumes on 3D-MRI and their impact on the performance of a breast conservative surgery (BCS).
    Breast J. 2021;27:252-255.
    PubMed         Abstract available

  83. KARANETZ I, Jin M, Nguyen K, Delmauro M, et al
    Evaluation of internal mammary lymph node biopsy during microsurgical breast reconstruction: An analysis of 230 consecutive patients.
    Breast J. 2021;27:7-12.
    PubMed         Abstract available

  84. YANAGISAWA W, Sedaghat N, Gordon-Thomson D
    Endovascular management of iatrogenic arteriovenous fistula of the breast.
    Breast J. 2021;27:52-55.
    PubMed         Abstract available

  85. BUTKOWSKY C, Gill G, Bisiker M, McCrady M, et al
    A novel educational method for creating a safe environment for transgender patients in a breast centre.
    Breast J. 2021;27:84-86.

  86. BENTZON T, Fosheim K
    Cystic fibroadenoma of the breast with a diffuse multicystic presentation.
    Breast J. 2021;27:478-480.
    PubMed         Abstract available

  87. MURA S, Caputo GG, Miotti G, Contessi Negrini F, et al
    Direct-to-implant, prepectoral breast reconstruction with Braxon((R)) dermal matrix: A single-center experience with 111 cases.
    Breast J. 2021;27:412-414.

  88. NICOSIA L, Bozzini A, Addante F, Renne G, et al
    Wireless ultrasound-guided vacuum-assisted breast biopsy: Experience in clinical practice at European Institute of Oncology.
    Breast J. 2021;27:514-520.
    PubMed         Abstract available

  89. TRENT G, Tong C, Brooks AD, Goodacre R, et al
    Improving time from check-in to start with preoperative SCOUT localization.
    Breast J. 2021;27:564-566.

  90. SHARP NE, Sachs DB, Melchior NM, Albaneze P, et al
    Does the false-negative rate for 1 or 2 negative sentinel nodes after neo-adjuvant chemotherapy translate into a high local recurrence rate?
    Breast J. 2021;27:335-344.
    PubMed         Abstract available

  91. MANSY AM, Abdellatif A, Abdel-Hadi M, Abou Elnagah G, et al
    Study of clinico-pathological changes before and after corticosteroid therapy in cases of idiopathic granulomatous mastitis.
    Breast J. 2021;27:486-488.

  92. DAVEY MG, Ryan EJ, Abd Elwahab S, Elliott JA, et al
    Clinicopathological correlates, oncological impact, and validation of Oncotype DX in a European Tertiary Referral Centre.
    Breast J. 2021;27:521-528.
    PubMed         Abstract available

  93. O'CONNELL RL, Di Micco R, Khabra K, Wolf L, et al
    Factors affecting volume and surface symmetry measured by three-dimensional surface imaging after breast-conserving therapy.
    Breast J. 2021;27:553-555.

  94. MASOOD S
    The significance of accurate diagnosis of encapsulated papillary carcinoma of the breast by core needle biopsy.
    Breast J. 2021;27:207-208.

  95. WHITE BN, Okoli J, Dixon JB, Yuan L, et al
    Use of a portable infrared 3D scanning device measuring limb volume in a safety net hospital breast clinic.
    Breast J. 2021;27:559-561.

  96. WOOD ME
    Is breast surgery time critical when neo-adjuvant therapy is not appropriate?
    Breast J. 2021;27:305-306.

  97. POWELL M, Gate T, Kalake O, Ranjith C, et al
    Magnetic Seed Localization (Magseed) for excision of impalpable breast lesions-The North Wales experience.
    Breast J. 2021;27:529-536.
    PubMed         Abstract available

  98. FOCASSIO CCM, de Marco L, Parente T, Dornas V, et al
    Deltopectoral insertion of port-a-cath for improved aesthetic aspect in women undergoing chemotherapy: A case series.
    Breast J. 2021;27:489-491.

  99. PATEL SA, Baltodano PA
    Editorial on predicting postoperative complications following mastectomy in the elderly: Evidence for the 5-factor frailty index.
    Breast J. 2021;27:507-508.

  100. FERREIRA ALS, Souza JA, Gibbons IL, Lellis RF, et al
    Clinical and imaging features of dermatofibrosarcoma protuberans in the breast.
    Breast J. 2021;27:92-94.

  101. KLUGMAN S, Schnabel F, Alim I, Loke J, et al
    Health care professionals' attitudes toward cancer gene panel testing.
    Breast J. 2021;27:499-500.

  102. YALAMANCHILI S, Madzia J, Dembinski D, Ortman M, et al
    A look at racial and socioeconomic disparities in post-mastectomy breast reconstruction at a midwestern academic hospital.
    Breast J. 2021;27:461-465.
    PubMed         Abstract available

  103. QUESADA AE, Zhang Y, Ptashkin R, Ho C, et al
    Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway.
    Breast J. 2021;27:314-321.
    PubMed         Abstract available

  104. HERNANDEZ-VILLAFRANCA S, Osorio I, Salido S, Qian S, et al
    Squamous cell carcinoma arising from an epidermal inclusion cyst in breast: An extremely rare diagnosis.
    Breast J. 2021;27:176-177.

  105. CHAR S, Bloom JA, Erlichman Z, Jonczyk MM, et al
    A comprehensive literature review of patient-reported outcome measures (PROMs) among common breast reconstruction options: What types of breast reconstruction score well?
    Breast J. 2021;27:322-329.
    PubMed         Abstract available

  106. TIRRELL AR, Abu El Hawa A, Bekeny JC, Del Corral G, et al
    Outcomes in chest feminization patients with a history of illicit hormone use and silicone injections.
    Breast J. 2021;27:352-358.
    PubMed         Abstract available

  107. NEAL JC, Saith S, Khong-McBride C, Kalantari BN, et al
    Does diagnostic mammography need to be a routine component of the initial evaluation of a breast symptom in women 30-39 years of age?
    Breast J. 2021;27:330-334.
    PubMed         Abstract available

  108. GENCO IS, Gur H, Hajiyeva S
    Lymphoma of the breast: A clinicopathologic analysis of 51 cases with a specific emphasis on patients with a history of breast carcinoma.
    Breast J. 2021;27:456-460.
    PubMed         Abstract available

  109. CHEN CY, Wang PJ, Huang CS, Chen KT, et al
    Increased asymmetry with larger breast size following the oncoplastic parallelogram mastopexy lumpectomy for cancer.
    Breast J. 2021;27:409-411.

  110. OGLIARI FR, Caspani F, Rossi L, Nerone M, et al
    Predictive variables of palbociclib dose reduction and its impact on survival outcomes: A retrospective bicentric study.
    Breast J. 2021;27:415-416.

  111. LISSIDINI G, Papa G, Girardi A, Ashoor AA, et al
    Schwannoma of the axillary region. Imaging findings, clinical pitfalls, and misdiagnosis.
    Breast J. 2021;27:273-275.

  112. KWONG A, Co M, Chen C, Wu A, et al
    Prospective clinical trial on high-intensity focused ultrasound for the treatment of breast fibroadenoma.
    Breast J. 2021;27:294-296.

  113. SIEGEL E, Rosa M, Khakpour N, Qin D, et al
    Erroneous diagnosis of primary fibrosarcoma of the breast: The value of the multidisciplinary breast team approach.
    Breast J. 2021;27:472-474.
    PubMed         Abstract available

  114. PRATHIBHA S, Beckwith H, Kratzke RA, Klein M, et al
    Synchronous breast carcinoma and peritoneal mesothelioma.
    Breast J. 2021;27:550-552.
    PubMed         Abstract available

  115. EICHLER C, Stephan S, Thangarajah F, Puppe J, et al
    Intraoperative central nipple biopsy in nipple-sparing mastectomy- A retrospective analysis of 211 patients.
    Breast J. 2021;27:363-368.
    PubMed         Abstract available

  116. DAMMEYER K, Alfonso AR, Diep GK, Kantar RS, et al
    Predicting postoperative complications following mastectomy in the elderly: Evidence for the 5-factor frailty index.
    Breast J. 2021;27:509-513.
    PubMed         Abstract available


  117. KURIAN AW, Hughes E, Simmons T, Bernhisel R, et al
    Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative.
    Cancer. 2021 Jul 6. doi: 10.1002/cncr.33767.
    PubMed         Abstract available

    Cancer Lett

  118. MININI M, Senni A, He X, Proietti S, et al
    miR-125a-5p impairs the metastatic potential in breast cancer via IP6K1 targeting.
    Cancer Lett. 2021 Jul 3. pii: S0304-3835(21)00326.
    PubMed         Abstract available

    Cancer Res

  119. Correction: Cyclophosphamide and Vinorelbine Activate Stem-Like CD8(+) T Cells and Improve Anti-PD-1 Efficacy in Triple-Negative Breast Cancer.
    Cancer Res. 2021;81:3426.

  120. HARRIS RJ, Cheung A, Ng JCF, Laddach R, et al
    Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes In Triple-Negative Breast Cancer.
    Cancer Res. 2021 Jun 15. pii: 0008-5472.CAN-20-3773.
    PubMed         Abstract available

    Clin Breast Cancer

  121. DONG L, Lin S, Zhong L, Nian D, et al
    Evaluation of Tucatinib in HER2-Positive Breast Cancer Patients With Brain Metastases: A United States-Based Cost-Effectiveness Analysis.
    Clin Breast Cancer. 2021 Jun 12. pii: S1526-8209(21)00146.
    PubMed         Abstract available

  122. MO H, Jazieh KA, Brinzevich D, Abraham J, et al
    A Review of Treatment-Induced Pulmonary Toxicity in Breast Cancer.
    Clin Breast Cancer. 2021 Jun 10. pii: S1526-8209(21)00142.
    PubMed         Abstract available

  123. HATZIPANAGIOTOU ME, Huber D, Gerthofer V, Hetterich M, et al
    Feasibility of ABUS as an Alternative to Handheld Ultrasound for Response Control in Neoadjuvant Breast Cancer Treatment.
    Clin Breast Cancer. 2021 May 26. pii: S1526-8209(21)00138.
    PubMed         Abstract available

  124. SCHLAFSTEIN A, Liu Y, Goyal S, Kahn S, et al
    Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients With Pathologic Negative Nodes After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2021 Jun 12. pii: S1526-8209(21)00148.
    PubMed         Abstract available

  125. FALCONE V, Reiser E, Grula L, Bago-Horvath Z, et al
    Correlation Between Preoperative Radiological and Postoperative Pathological Tumor Size in Patients With HER2(+) Breast Cancer After Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab.
    Clin Breast Cancer. 2021 Jun 10. pii: S1526-8209(21)00145.
    PubMed         Abstract available

    Eur J Cancer

  126. ARUN BK, Han HS, Kaufman B, Wildiers H, et al
    Efficacy and safety of first-line veliparib and carboplatin-paclitaxel in patients with HER2- advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial.
    Eur J Cancer. 2021;154:35-45.
    PubMed         Abstract available

  127. YUAN Y, Lee JS, Yost SE, Frankel PH, et al
    Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer.
    Eur J Cancer. 2021;154:11-20.
    PubMed         Abstract available

    Eur J Surg Oncol

  128. CABIOGLU N, Karanlik H, Yildirim N, Muslumanoglu M, et al
    Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study.
    Eur J Surg Oncol. 2021 Jun 24. pii: S0748-7983(21)00587.
    PubMed         Abstract available

    Eur Radiol

  129. LEE JY, Lee KS, Seo BK, Cho KR, et al
    Radiomic machine learning for predicting prognostic biomarkers and molecular subtypes of breast cancer using tumor heterogeneity and angiogenesis properties on MRI.
    Eur Radiol. 2021 Jul 5. pii: 10.1007/s00330-021-08146.
    PubMed         Abstract available

  130. KRUG KB, Burke CJ, Weiss K, Baltzer PAT, et al
    Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging.
    Eur Radiol. 2021 Jul 3. pii: 10.1007/s00330-021-08069.
    PubMed         Abstract available

    Exp Cell Res

  131. HUANG W, Chen J, Liu X, Liu X, et al
    MIER3 induces epithelial-mesenchymal transition and promotes breast cancer cell aggressiveness via forming a co-repressor complex with HDAC1/HDAC2/Snail.
    Exp Cell Res. 2021 Jul 6:112722. doi: 10.1016/j.yexcr.2021.112722.
    PubMed         Abstract available


  132. MURAD R, Avanes A, Ma X, Geng S, et al
    Transcriptome and chromatin landscape changes associated with trastuzumab resistance in HER2+ breast cancer cells.
    Gene. 2021 Jul 2:145808. doi: 10.1016/j.gene.2021.145808.
    PubMed         Abstract available

    Int J Cancer

  133. ZHANG L, Zhou M, Liu Y, Du F, et al
    Is It Beneficial for Patients with pT1-2N1M0 Breast Cancer to Receive Post-Mastectomy Radiotherapy? An Analysis Based on RecurIndex Assay.
    Int J Cancer. 2021 Jul 5. doi: 10.1002/ijc.33730.
    PubMed         Abstract available

    J Biol Chem

  134. WANG T, Xia D, Li N, Wang C, et al
    Withdrawal: Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis.
    J Biol Chem. 2021;296:100763.

  135. LIU Q, Tan Q, Zheng Y, Chen K, et al
    Withdrawal: Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation.
    J Biol Chem. 2021;296:100757.

    J Clin Oncol

  136. KAWAMURA Y, Shimomura A, Shimizu C
    Who Can Receive the Benefit of a Palbociclib Add-On in Patients With HR+HER2- Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy?
    J Clin Oncol. 2021 Jul 6:JCO2101174. doi: 10.1200/JCO.21.01174.


  137. MASUDA J, Ozaki Y, Hara F, Kitano S, et al
    Pembrolizumab plus chemotherapy in triple-negative breast cancer.
    Lancet. 2021;398:24.

  138. CORTES J, Rugo HS, Guo Z, Karantza V, et al
    Pembrolizumab plus chemotherapy in triple-negative breast cancer - Authors' reply.
    Lancet. 2021;398:24-25.

  139. MUSALLAM R, Alnajjar M, Al-Shurafa A, Bottcher B, et al
    Clinical and pathological characteristics and hormone receptor status of women with breast cancer in the European Gaza Hospital: a retrospective chart-based review.
    Lancet. 2021;398 Suppl 1:S38.
    PubMed         Abstract available

    NPJ Breast Cancer

  140. LI J, Downs BM, Cope LM, Fackler MJ, et al
    Automated and rapid detection of cancer in suspicious axillary lymph nodes in patients with breast cancer.
    NPJ Breast Cancer. 2021;7:89.
    PubMed         Abstract available

  141. LIU F, Hardiman T, Wu K, Quist J, et al
    Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication.
    NPJ Breast Cancer. 2021;7:86.
    PubMed         Abstract available

  142. BOYCE-FAPPIANO D, Bedrosian I, Shen Y, Lin H, et al
    Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis.
    NPJ Breast Cancer. 2021;7:87.
    PubMed         Abstract available


  143. HAMALIAN S, Guth R, Runa F, Sanchez F, et al
    A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers.
    Oncogene. 2021 Jul 8. pii: 10.1038/s41388-021-01906.
    PubMed         Abstract available

    PLoS One

  144. LI Z, Zhang J, Zou W, Xu Q, et al
    The methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism is associated with breast cancer subtype susceptibility in southwestern China.
    PLoS One. 2021;16:e0254267.
    PubMed         Abstract available

    Radiol Artif Intell

  145. HU Q, Whitney HM, Li H, Ji Y, et al
    Improved Classification of Benign and Malignant Breast Lesions Using Deep Feature Maximum Intensity Projection MRI in Breast Cancer Diagnosis Using Dynamic Contrast-enhanced MRI.
    Radiol Artif Intell. 2021;3:e200159.
    PubMed         Abstract available

    Radiol Cardiothorac Imaging

  146. ELSHERIF SB, Sharma S, Green K, Fischer A, et al
    Recurrent Metastatic Breast Cancer in Internal Mammary Lymph Nodes along the Translocated Left Internal Mammary Artery Bypass Graft.
    Radiol Cardiothorac Imaging. 2021;3:e210042.
    PubMed         Abstract available


  147. CHAN HP, Helvie MA
    Using Single-View Wide-Angle DBT with AI for Breast Cancer Screening.
    Radiology. 2021 Jul 6:211203. doi: 10.1148/radiol.2021211203.

  148. PINTO MC, Rodriguez-Ruiz A, Pedersen K, Hofvind S, et al
    Impact of Artificial Intelligence Decision Support Using Deep Learning on Breast Cancer Screening Interpretation with Single-View Wide-Angle Digital Breast Tomosynthesis.
    Radiology. 2021 Jul 6:204432. doi: 10.1148/radiol.2021204432.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.